MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines

Glioblastoma (GBM, grade IV glioma) represents the most aggressive brain tumor and patients with GBM have a poor prognosis. Until now surgical resection followed by radiotherapy and temozolomide (TMZ) treatment represents the standard strategy for GBM. We showed that the imidazobenzoxazin-5-thione M...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Alessio Malacrida, Alessandro Di Domizio, Angela Bentivegna, Giacomo Cislaghi, Eleonora Messuti, Silvia Maria Tabano, Carlo Giussani, Valentina Zuliani, Mirko Rivara, Gabriella Nicolini
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-01-01
Sarja:	Biology
Aiheet:	glioblastoma temozolomide patient-derived GSCs ALKBH2
Linkit:	https://www.mdpi.com/2079-7737/11/1/70
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!